MicroRNAs as Future Treatment Tools and Diagnostic Biomarkers in Alzheimer’s Disease
Book chapter (November 2022)
The most recent citing publications are shown below. View all 46 publications that cite this research output on Dimensions.
Natural medicine HLXL targets multiple pathways of amyloid-mediated neuroinflammation and immune response in treating alzheimer's disease
Article in Phytomedicine (May 2022)
Association of the Protein-Quality-Control Protein Ubiquilin-1 With Alzheimer’s Disease Both in vitro and in vivo
Article in Frontiers in Neuroscience (March 2022)